We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Clinical Collaboration

News List

Bristol-Myers Squibb, Compugen Announce Clinical Collaboration americanpharmaceuticalreview
October 12, 2018
Bristol-Myers Squibb and Compugen announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugen's COM701, an investigational anti-PVRIG antibody, in combination with Bristol-Myers Squibb's pro
Bristol-Myers Squibb and Compugen announce clinical collaboration to evaluate therapeutic regimen in advanced solid tumors worldpharmanews
October 12, 2018
Bristol-Myers Squibb Company (NYSE: BMY) and Compugen (NASDAQ: CGEN) today announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugen's COM701, an investigational anti-PVRIG antibody, in co
BMS and Clovis Oncology Enter Clinical Collaboration contractpharma
August 04, 2017
Will evaluate combination of Opdivo and Rubraca in Phase 2 and pivotal Phase 3 clinical trials in multiple tumor types
Bristol-Myers Squibb announces immunotherapy clinical collaboration with Janssen worldpharmanews
January 06, 2017
Bristol-Myers Squibb Company (NYSE:BMY) today announced a new clinical research collaboration with Janssen Biotech, Inc.